Saturday, October 31, 2026
Data from SEC filings, checked daily
Public filings, plainly told
Summarize with AIChatGPTClaudePerplexityGoogle AIGrokCopilot
Data updated Oct 31, 2026·New filings added every weekday·Weekly prices as of Oct 2·What changed·
Insider tradingForm 4

LEXICON PHARMACEUTICALS, INC. (LXRX) Insider Trading

7 open-market trades reported since Feb 18, 2026: 7 purchases worth $723K and 0 sales worth $0.

By insider

InsiderRoleBuysBoughtSellsSoldLatest
Raymond DebbaneDirector7$723K0$0Feb 27, 2026

All trades

LXRX insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueScoreHolding3 mo. afterFiling
Feb 27Feb 25Raymond DebbaneDirectorDirector▲ BUY2,0001.49$3K11+0.1%Form 4 ↗
Feb 25Feb 23Raymond DebbaneDirectorDirector▲ BUY100,0001.47$147K23+5.5%Form 4 ↗
Feb 23Feb 20Raymond DebbaneDirectorDirector▲ BUY100,0001.48$148K23+5.9%Form 4 ↗
Feb 23Feb 19Raymond DebbaneDirectorDirector▲ BUY50,0001.44$72K14+3.0%Form 4 ↗
Feb 18Feb 18Raymond DebbaneDirectorDirector▲ BUY133,6881.32$176K23+8.8%Form 4 ↗
Feb 18Feb 17Raymond DebbaneDirectorDirector▲ BUY76,8571.31$101K23+5.3%Form 4 ↗
Feb 18Feb 13Raymond DebbaneDirectorDirector▲ BUY57,9521.31$76K14+4.2%Form 4 ↗
Source: SEC Form 4 filings, retrieved Oct 31, 2026. How we read filings

Report an error

Tell us what looks wrong on this page. We check every report against the original filing and fix mistakes on our corrections page.

Share this trade
XTelegram
My Desk · free

Sign in to follow

Follow stocks, members of Congress, famous investors and funds, and see what's new each time you come back.